As drug-pricing proposals proliferate at the federal level, states are taking their own steps to rein in sticker prices. That fight hasn’t been easy, what with the pharma industry’s lobbying power. But it’s not impossible, either. More: Maryland, Massachusetts statehouses press drug-pricing bills as
read moreAfter AbbVie walked away from its proposed Shire buy, Shire investors said AbbVie never disclosed its true intentions—avoiding U.S. taxes by moving its official headquarters to Ireland. Now, the sides have agreed to settle their legal fight. More: AbbVie, Shire
read moreThe approval is based on results from the Phase III KEYNOTE-042 trial. More: MSD’s Keytruda granted FDA extension Source: News
read moreNobel laureate demands a bigger cut of Ono’s Opdivo revenues; on a selloff spree, Takeda is said to be scouting bidders for its Latin American business; the Trump administration forces a Chinese genomics investor out of a U.S. health service
read morePerformance improves in some areas and ambulance response times hit target for the first time ever, but A&E admittances are continuing to rise and cancer patients are still waiting too long for treatment. More: Latest NHS stats show “strain on
read moreThe UK has been granted a six-month Brexit extension to October 31. More: New Brexit date is a ‘relief’, says NHS Confederation Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals